Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$6.04
-0.4%		$5.72
$3.36
▼
$6.72
$634.82M0.141.28 million shs3.90 million shs
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$10.55
$11.71
$9.62
▼
$21.34
$746.73M0.0117,656 shs7,853 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
0.00%-4.13%+1.77%+10.84%+45.77%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.00%-5.89%-10.97%-16.99%-29.10%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$6.04
-0.4%		$5.72
$3.36
▼
$6.72
$634.82M0.141.28 million shs3.90 million shs
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$10.55
$11.71
$9.62
▼
$21.34
$746.73M0.0117,656 shs7,853 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
0.00%-4.13%+1.77%+10.84%+45.77%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.00%-5.89%-10.97%-16.99%-29.10%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
1.50
Reduce$7.3020.96% Upside
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
2.20
Hold$38.67266.51% Upside

Current Analyst Ratings Breakdown

Latest PHAR, EGY, GKP, and TLW Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/14/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$37.00
8/7/2026
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
8/7/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
8/3/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$37.00 ➝ $38.00
7/31/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
7/30/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
(Data available from 9/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$359.27M1.77$1.01 per share5.96$4.25 per share1.42
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$376.13M1.99$0.20 per share52.60$3.95 per share2.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
-$41.39M-$1.06N/A25.15N/A-31.11%-14.36%-6.41%11/9/2026 (Estimated)
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$2.85M$0.1287.9242.20N/A2.51%3.40%1.90%11/5/2026 (Estimated)

Latest PHAR, EGY, GKP, and TLW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$0.0630$0.02-$0.0430$0.02$99.52 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$0.254.14%N/AN/A N/A
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
N/AN/AN/AN/AN/A

Latest PHAR, EGY, GKP, and TLW Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2026
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
quarterly$0.06254.22%8/21/20268/21/20269/22/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
0.60
0.44
0.41
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.34
3.01
2.31

Institutional Ownership

CompanyInstitutional Ownership
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
50.32%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.03%

Insider Ownership

CompanyInsider Ownership
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
3.00%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
2.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
281105.19 million102.04 millionOptionable
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
40770.78 million69.31 millionNot Optionable

Recent News About These Companies

MAC Alpha Capital Management LP Makes New $29.84 Million Investment in Pharming Group N.V. Sponsored ADR $PHAR
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-mac-alpha-capital-management-lp-makes-new-2984-million-investment-in-pharming-group-nv-sponsored-adr-phar-2026-09-21/
FY2027 EPS Estimates for Pharming Group Cut by HC Wainwright
September 18 at 1:28 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31029678
Rhythm Pharmaceuticals (NASDAQ:RYTM) versus Pharming Group (NASDAQ:PHAR) Financial Comparison
September 17, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31028392
FY2026 EPS Estimates for Pharming Group Cut by HC Wainwright
September 17, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31027650
Pharming Group (PHAR) Expands Joenja’s Pediatric Label. Can Growth Offset RUCONEST Weakness?
September 16, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/news/pharming-group-phar-expands-joenjas-pediatric-label-can-growth-offset-ruconest-weakness-1837438/
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - What's Next?
September 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-pharming-group-nasdaq-phar-sees-strong-trading-volume-whats-next-2026-09-16/
FY2027 EPS Forecast for Pharming Group Lowered by Analyst
September 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-fy2027-eps-forecast-for-pharming-group-lowered-by-analyst-2026-09-16/
HC Wainwright Reiterates Buy Rating for Pharming Group (NASDAQ:PHAR)
September 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31025810
FY2026 EPS Forecast for Pharming Group Decreased by Analyst
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-fy2026-eps-forecast-for-pharming-group-decreased-by-analyst-2026-09-15/
Pharming Group N.V. (PHAR) Presents at H.C. Wainwright 28th Annual Global Investment Conference - Slideshow
September 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946057-pharming-group-n-v-phar-presents-at-h-c-wainwright-28th-annual-global-investment-conference
Pharming Group's (PHAR) "Buy" Rating Reiterated at HC Wainwright
September 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-pharming-groups-phar-buy-rating-reiterated-at-hc-wainwright-2026-09-14/
Pharming Group Obtains US FDA Nod for Rare Primary Immunodeficiency Drug Joenja
September 14, 2026  |  marketscreener.comM
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Update
September 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/options-pharming-group-nv-sponsored-adr-nasdaq-phar-short-interest-update-2026-09-12/
Pharming Gets FDA Approval for Joenja to Treat APDS in Children Aged 4-11
September 11, 2026  |  marketscreener.comM
Pharming Gets FDA Approval For Joenja In Children With APDS
September 11, 2026  |  rttnews.comhttps://www.rttnews.com/3690452/pharming-gets-fda-approval-for-joenja-in-children-with-apds.aspx
FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.
September 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/fda-approves-pharming-joenja-first-180000437.html
FDA approves Pharming's Joenja® as first treatment for children with APDS in the U.S.
September 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/11/3360484/0/en/fda-approves-pharming-s-joenja-as-first-treatment-for-children-with-apds-in-the-u-s.html
Pharming Group (NASDAQ:PHAR) Shares Gap Down - Time to Sell?
September 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-pharming-group-nasdaq-phar-shares-gap-down-time-to-sell-2026-09-10/
Pharming: Faltering Rare-Disease Franchise With Two Potentially Transformative Late-Stage Assets
September 9, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4944187-pharming-faltering-rare-disease-franchise-with-two-potentially-transformative-late-stage-assets
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Given Consensus Recommendation of "Hold" by Brokerages
September 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-pharming-group-nv-sponsored-adr-nasdaq-phar-given-consensus-recommendation-of-hold-by-brokerages-2026-09-07/
Pharming Group (NASDAQ:PHAR) Shares Gap Up - Should You Buy?
September 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-pharming-group-nasdaq-phar-shares-gap-up-should-you-buy-2026-09-02/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Foldable Apple smartphone displayed on a table with a lit Apple logo and city skyline in the background.
Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
By Sam Quirke | August 30, 2026
Williams Sonoma circular logo sign on a wall surrounded by kitchenware, bowls, a pepper mill, and cutting board.
Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
By Thomas Hughes | August 26, 2026
A drone with a camera gimbal flies in a dark room above the Draganfly company logo.
Radar Anomaly: Draganfly’s Options Surge Signals Strategy Shift
By Jeffrey Neal Johnson | September 1, 2026
Scientist handles blood sample in lab, symbolizing early cancer detection.
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
By Bridget Bennett | September 6, 2026
Palo Alto Networks logo displayed amid a server data center and a digital globe with network connections.
Palo Alto Networks Is Expensive—But Its Growth Is Accelerating
By Thomas Hughes | September 3, 2026
Vaalco Energy stock logo

Vaalco Energy NYSE:EGY

$6.04 -0.03 (-0.41%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$6.06 +0.02 (+0.41%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

VAALCO Energy, Inc., an independent energy company, engages in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids in Gabon, Egypt, Equatorial Guinea, and Canada. The company holds 58.8% interest in the Etame production sharing contract related to the Etame Marin block covering an area of approximately 46,200 gross acres located offshore in the Republic of Gabon in West Africa. It also owns 100% interest in the Eastern Desert, which contains West Gharib, West Bakr and North West Gharib merged concessions covering as area of approximately 45,067 acres, as well as Western Desert, which contains the South Ghazalat concession covering as area of approximately 7,340 acres located in Egypt. In addition, the company production and working interests in Cardium light oil and Mannville liquids-rich gas assets covering as area of 47,400 gross acres located near the north of Calgary, Alberta; and an undeveloped block offshore Equatorial Guinea, West Africa. VAALCO Energy, Inc. was incorporated in 1985 and is headquartered in Houston, Texas.

Pharming Group stock logo

Pharming Group NASDAQ:PHAR

$10.55 0.00 (0.00%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$10.55 0.00 (0.00%)
As of 04:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas